Post-earnings recap
Reported
Wed, Apr 29, 2026
EPS actual
$10.31
EPS est.
$9.96
EPS surprise
+3.46%
1-day move
+5.83%
Humana's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction remained flat, suggesting that investors are weighing the mixed signals from the earnings call.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $10.31 | $10.20 | +3.46% |
| Revenue | N/A | $39.4B | N/A |
Management expressed a cautious view on the current market environment. They acknowledged the challenges but reaffirmed their focus on operational efficiency.
Management highlighted the ongoing challenges in the healthcare sector.
They emphasized their commitment to maintaining service quality despite market pressures.
Humana Inc. is a health care company that provides managed health care services. With a focus on Medicare and Medicaid, it plays a crucial role in the health care sector, especially as the population ages and demand for health services increases.
Last quarter
In the last quarter, Humana reported an EPS of -$3.96, slightly better than expectations. The stock reacted negatively, dropping 3.25% the following day.
EPS beat streak
4Q
EPS beat rate
88%
Avg EPS surprise
+9.64%
Avg 1-day reaction
+0.48%
Analysts are cautiously optimistic about Humana's upcoming earnings, with expectations for a solid EPS and revenue growth. However, uncertainty remains due to recent performance fluctuations.
Bull case
If Humana exceeds EPS expectations, it could signal strong operational efficiency and growth potential, leading to a positive market reaction.
Bear case
Conversely, if the company misses EPS estimates or shows declining revenue trends, it could raise concerns about its market competitiveness and profitability.
Key metrics to watch
EPS
$10.20Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
$39.4BRevenue figures will indicate the overall growth and demand for Humana's services, which is essential for assessing its market position.
The print will turn on these.
Q1
Will Humana's EPS exceed the consensus estimate of $10.20?
A beat on EPS could indicate stronger-than-expected profitability and operational efficiency, which would be crucial for investor confidence.
Q2
What will be the revenue figure compared to the consensus of $39.4B?
Revenue growth is vital for assessing the company's market position and ability to attract and retain customers.
—
Est. EPS
$1.52
Est. Rev
$3.6B
Impl. Move
±39.2%
Why consensus could be wrong
The consensus may underestimate Humana's ability to manage costs effectively, especially given its recent EPS surprises that exceeded expectations.
Supporting evidence
Humana has an 88% EPS beat rate in recent quarters, suggesting strong operational management.
The options market is pricing a larger move than historical averages, indicating potential for a surprise.
Recent trends in the health care sector suggest increased demand for managed care services, which Humana is well-positioned to capitalize on.
Key risk
If Humana's revenue comes in below $37.2B, it could undermine confidence in its growth trajectory.
Pre-commit to what would confirm each case.
This quarter's performance will be closely scrutinized as it could signal the company's ability to navigate market challenges and capitalize on growth opportunities.
Bull confirmed if
An EPS of $10.50 or higher would confirm strong operational performance and growth potential.
Bear confirmed if
An EPS below $9.00 would raise significant concerns about profitability and market competitiveness.
What the market is pricing for the move.
Implied Move
±8.55%
Historical Avg
±5.2%
The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.
Options are pricing ±8.8% while HUM has averaged ±5.2% over the last 8 prints — setup is pricing rich.
ATM IV
1.2%
30d HV
36.5%
Smart-money positioning from the most recent 13F filings.
Institutional
100.95%
of float
Insider
0.21%
of float
Holders
1,304
institutions
Top Holders· as of Jun 2026
Dodge & Cox Inc.
10,940,380 sh · $4.3B
9.11%
-3.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Humana beats expectations, history suggests the stock could rise by around 3.1%, confirming a positive outlook for the company.
In line / cautious
If results are in line with expectations, the stock may experience a muted response, reflecting cautious investor sentiment.
Miss
A miss could lead to a significant drop, with history suggesting an average decline of around 12.4%, indicating heightened concerns about the company's future.
The lines on the call that would change the story.
Blackrock Inc.
10,417,803 sh · $4.1B
8.68%
2.1%
Vanguard Capital Management LLC
7,843,620 sh · $3.1B
6.53%
0.1%
Vanguard Portfolio Management LLC
5,818,956 sh · $2.3B
4.85%
0.2%
State Street Corporation
5,457,072 sh · $2.2B
4.54%
0.1%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.